HuGE Literature Finder
Records
1
-
5
CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity. Molecular cancer 2021 5 20 (1): 75. Dong Zhao-Ru, Ke Ai-Wu, Li Tao, Cai Jia-Bing, Yang Ya-Fei, Zhou Wei, Shi Guo-Ming, Fan J |
TCF21 genetic polymorphisms and breast cancer risk in Chinese women. Oncotarget 2016 Jun . Gao Xueren, Yang Jiaojiao, Wang Mingxi, Zhang Jianqio |
An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese. Oncotarget 2015 12 7 (3): 2754-64. Wang Yongqiang, Yu Yuan, Ye Rui, Zhang Duo, Li Qiaoling, An Dan, Fang Lu, Lin Youcheng, Hou Yong, Xu Abai, Fu Yu, Lu Wei, Chen Xin, Chen Mingwei, Zhang Meng, Jiang Huiling, Zhang Chuanxia, Dong Pei, Li Chong, Chen Jun, Yang Guosheng, Liu Chunxiao, Cai Zhiming, Zhou Fangjian, Wu So |
Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma. Cellular oncology (Dordrecht) 2013 3 36 (3): 213-24. Weiss Daniel, Stockmann Christian, Schrödter Katrin, Rudack Claud |
Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer. Molecular cancer 2008 7 7 62. Anglim Paul P, Galler Janice S, Koss Michael N, Hagen Jeffrey A, Turla Sally, Campan Mihaela, Weisenberger Daniel J, Laird Peter W, Siegmund Kimberly D, Laird-Offringa Ite |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: